Cancer and COVID-19 Experiences at African Cancer Centers: The Silver Lining.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
03 2021
Historique:
entrez: 24 3 2021
pubmed: 25 3 2021
medline: 7 4 2021
Statut: ppublish

Résumé

The COVID-19 pandemic significantly disrupted cancer care in Africa, further exposing major health disparities. This paper compares and contrasts the experiences of 15 clinicians in six different African cancer centers to highlight the positive aspects (silver linings) in an otherwise negative situation. Data are from personal experience of the clinicians working at the six cancer centers blended with what is available in the literature. The impact of COVID-19 on cancer care appeared to vary not only across the continent but also over cancer centers. Different factors such as clinic location, services offered, available resources, and level of restrictions imposed because of COVID-19 were associated with these variations. Collectively, delays in treatment and limited access to cancer care were commonly reported in the different regions. There is a lack of data on cancer patients with COVID-19 and online COVID-19 and cancer registries for Africa. Analysis of the available data, however, suggests a higher mortality rate for cancer patients with COVID-19 compared with those without cancer. Positive or silver linings coming out of the pandemic include the adoption of hypofractionated radiation therapy and teleoncology to enhance access to care while protecting patients and staff members. Increasing collaborations using online technology with oncology health professionals across the world are also being seen as a silver lining, with valuable sharing of experiences and expertise to improve care, enhance learning, and reduce disparities. Advanced information and communication technologies are seen as vital for such collaborations and could avail efforts in dealing with the ongoing pandemic and potential future crises.

Identifiants

pubmed: 33760639
doi: 10.1200/GO.20.00564
pmc: PMC8081519
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

410-415

Subventions

Organisme : NCI NIH HHS
ID : R01 CA239042
Pays : United States

Références

J Infect Dis. 2020 Jun 29;222(2):214-222
pubmed: 32432672
SN Compr Clin Med. 2020 Jun 25;:1-8
pubmed: 32838147
Ecancermedicalscience. 2020 May 28;14:1052
pubmed: 32565905
N Engl J Med. 2020 Jun 11;382(24):e95
pubmed: 32469479
Lancet Glob Health. 2020 May;8(5):e631-e632
pubmed: 32246918
Ecancermedicalscience. 2020 Apr 01;14:ed97
pubmed: 32269597
Pan Afr Med J. 2020 Jul 06;36:153
pubmed: 32874417
JCO Glob Oncol. 2020 Apr;6:667-678
pubmed: 32343628
Ecancermedicalscience. 2020 Jul 17;14:1075
pubmed: 32863869
Quant Imaging Med Surg. 2020 Jun;10(6):1204-1207
pubmed: 32550130
Science. 2020 May 1;368(6490):445
pubmed: 32355004
Front Psychiatry. 2020 Sep 11;11:564452
pubmed: 33061919
JCO Glob Oncol. 2020 Sep;6:1461-1471
pubmed: 32997537
J Glob Health. 2012 Dec;2(2):020404
pubmed: 23289079
Lancet Oncol. 2020 May;21(5):621-622
pubmed: 32251623

Auteurs

Linda Grossheim (L)

Summit Cancer Centers, Post Falls, ID.

Paul Ruff (P)

University of the Witwatersrand, Johannesburg, South Africa.

Twalib Ngoma (T)

Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Verna Vanderpuye (V)

National Center for Radiotherapy, Korlebu Teaching Hospital, Accra, Ghana.

Gladys Mwango (G)

University of Nairobi, Nairobi, Kenya.

Primus Ochieng (P)

University of Nairobi, Nairobi, Kenya.

Dennis Palmer (D)

Mbingo Baptist Hospital, Northwest, Cameroon.

Francine Kouya (F)

Mbingo Baptist Hospital, Northwest, Cameroon.

Nwamaka Lasebikan (N)

University of Nigeria-Teaching Hospital, Enugu, Nigeria.

Atara Ntekim (A)

University College Hospital, Ibadan, Nigeria.

Mamsau Ngoma (M)

Ocean Road Cancer Institute, Dar es Salaam, Tanzania.

Noella Bih (N)

Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Abba Malloum (A)

National Hospital, Bloemfontein, South Africa.

Ahmed Elzawawy (A)

Suez Canal University, Ismailia, Egypt.

David Kerr (D)

John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.

Wilfred Ngwa (W)

Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH